$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000111748016000045 Filed on May 09, 2016

Income Statement

Concept	2016 Q2	2016 Q1	2015 Q1
Revenue	$1.841M	$1.228M	$1.238M
YoY Change	-55.56%	-0.81%	58.72%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.610M	$6.920M	$6.123M
YoY Change	-9.85%	13.02%	129.15%
% of Gross Profit
Research & Development	$13.76M	$20.94M	$17.44M
YoY Change	-37.06%	20.02%	110.37%
% of Gross Profit
Depreciation & Amortization	$260.0K	$267.0K	$114.0K
YoY Change	73.33%	134.21%	128.0%
% of Gross Profit
Operating Expenses	$20.37M	$27.86M	$23.57M
YoY Change	-30.0%	18.22%	114.95%
Operating Profit	-$18.53M	-$26.63M	-$22.33M
YoY Change	-25.75%	19.27%	119.26%
Interest Expense	$380.0K	$370.0K	$60.00K
YoY Change	171.43%	516.67%	-130.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$18.15M	-$26.26M	-$22.27M
YoY Change	-26.87%	17.92%	114.55%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$18.15M	-$26.26M	-$22.27M
YoY Change	-26.87%	17.94%	114.51%
Net Earnings / Revenue	-985.77%	-2138.44%	-1798.55%
Basic Earnings Per Share
Diluted Earnings Per Share	-$392.8K	-$568.6K	-$532.1K
COMMON SHARES
Basic Shares Outstanding	46.21M shares	46.18M shares	41.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$272.8M	$263.3M	$174.5M
YoY Change	5.61%	50.89%	74.67%
Cash & Equivalents	$32.06M	$27.50M	$55.61M
Short-Term Investments	$240.8M	$235.8M	$118.9M
Other Short-Term Assets	$4.800M	$4.900M	$1.800M
YoY Change	-44.83%	172.22%	28.57%
Inventory
Prepaid Expenses
Receivables	$313.0K	$566.0K	$977.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$277.9M	$268.8M	$177.3M
YoY Change	3.19%	51.64%	74.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.020M	$3.006M	$1.329M
YoY Change	51.3%	126.19%	232.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$29.80M	$52.40M	$95.20M
YoY Change	-80.15%	-44.96%
Other Assets	$93.00K	$64.00K	$297.0K
YoY Change	16.25%	-78.45%
Total Long-Term Assets	$32.92M	$55.43M	$96.87M
YoY Change	-78.38%	-42.77%	19273.0%
TOTAL ASSETS
Total Short-Term Assets	$277.9M	$268.8M	$177.3M
Total Long-Term Assets	$32.92M	$55.43M	$96.87M
Total Assets	$310.8M	$324.2M	$274.1M
YoY Change	-26.26%	18.28%	168.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.217M	$3.568M	$6.920M
YoY Change	-57.05%	-48.44%	284.44%
Accrued Expenses	$6.311M	$6.638M	$6.630M
YoY Change	-41.34%	0.12%	248.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$2.900M
YoY Change			-48.21%
Total Short-Term Liabilities	$10.53M	$10.21M	$16.44M
YoY Change	-52.28%	-37.93%	76.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$200.0K
YoY Change	-100.0%	-100.0%	-93.1%
Other Long-Term Liabilities	$300.0K	$300.0K	$161.0K
YoY Change	123.88%	86.34%	-59.75%
Total Long-Term Liabilities	$300.0K	$300.0K	$161.0K
YoY Change	123.88%	86.34%	-95.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.53M	$10.21M	$16.44M
Total Long-Term Liabilities	$300.0K	$300.0K	$161.0K
Total Liabilities	$10.83M	$10.54M	$16.60M
YoY Change	-51.19%	-36.54%	32.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$383.8M	-$365.7M	-$244.3M
YoY Change	42.62%	49.68%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$300.0M	$313.7M	$257.5M
YoY Change
Total Liabilities & Shareholders Equity	$310.8M	$324.2M	$274.1M
YoY Change	-26.26%	18.28%	168.22%

Cashflow Statement

Concept	2016 Q2	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$18.15M	-$26.26M	-$22.27M
YoY Change	-26.87%	17.94%	114.51%
Depreciation, Depletion And Amortization	$260.0K	$267.0K	$114.0K
YoY Change	73.33%	134.21%	128.0%
Cash From Operating Activities	-$12.55M	-$28.64M	-$18.84M
YoY Change	-45.48%	52.0%	106.66%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	$232.0K	$133.0K
YoY Change	-67.07%	74.44%	34.34%
Acquisitions
YoY Change
Other Investing Activities	$17.36M	$35.60M	-$54.59M
YoY Change	-126.64%	-165.21%	-12.85%
Cash From Investing Activities	$17.09M	$35.37M	-$54.72M
YoY Change	-125.9%	-164.63%	-12.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	$166.0K	$701.0K
YoY Change	-99.99%	-76.32%	-200.14%
NET CHANGE
Cash From Operating Activities	-12.55M	-$28.64M	-$18.84M
Cash From Investing Activities	17.09M	$35.37M	-$54.72M
Cash From Financing Activities	20.00K	$166.0K	$701.0K
Net Change In Cash	4.560M	$6.898M	-$72.86M
YoY Change	-93.68%	-109.47%	0.42%
FREE CASH FLOW
Cash From Operating Activities	-$12.55M	-$28.64M	-$18.84M
Capital Expenditures	-$270.0K	$232.0K	$133.0K
Free Cash Flow	-$12.28M	-$28.87M	-$18.97M
YoY Change	-44.68%	52.16%	105.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3596000	USD
CY2016Q1	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3426000	USD
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46213134	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10458000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3568000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2432000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	566000	USD
CY2015Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-425000	USD
CY2016Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-397000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9721000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6638000	USD
CY2015Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2939000	USD
CY2016Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2247000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-764000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-343000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	675591000	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	679672000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2402000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3915000	USD
CY2015Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	-12000	USD
CY2016Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	-12000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	26000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1409000	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	314000	shares
CY2015Q4	us-gaap	Assets Assets	355992000	USD
CY2016Q1	us-gaap	Assets Assets	324238000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	228837000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	268805000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	323769000	USD
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	288195000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	49000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	766000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	392000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	324533000	USD
CY2016Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	288538000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	766000	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	392000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	317521000	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	170800000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	766000	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	392000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	317521000	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	170800000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	199729000	USD
CY2016Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	235832000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	52363000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	286959000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	234596000	USD
CY2015Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	180	securities
CY2016Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	57	securities
CY2015Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	124040000	USD
CY2016Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	52363000	USD
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	180	securities
CY2016Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	57	securities
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2016Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128462000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55605000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20605000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27503000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-72857000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6898000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46162525	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46210768	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46162525	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46210768	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2016Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2015Q1	us-gaap	Contracts Revenue ContractsRevenue	1238000	USD
CY2016Q1	us-gaap	Contracts Revenue ContractsRevenue	1228000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	354000	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	331000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	114000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	267000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2015Q4	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	1.54
CY2015Q4	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2015Q4	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P169D
CY2015Q4	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.75
CY2015Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0044
CY2015Q4	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.10
CY2016Q1	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.05
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	511000	USD
CY2016Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod	P18M
CY2015Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2016Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6123000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6924000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9985000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	871000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1879000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-832000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1160000	USD
CY2015Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	63000	USD
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	372000	USD
CY2015Q1	us-gaap	Interest Paid Net InterestPaidNet	70000	USD
CY2016Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	20533000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	10537000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355992000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	324238000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20179000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10206000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	701000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	166000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54719000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35367000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18839000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28635000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-22266000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-26260000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	23567000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	27860000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22329000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26632000	USD
CY2015Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3186000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	965000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	64000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	625000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	421000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21641000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25839000	USD
CY2015Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2016Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2015Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	65232000	USD
CY2016Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	232000	USD
CY2015Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	26709000	USD
CY2016Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6071000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4904000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	461000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	33000	USD
CY2015Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	36352000	USD
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	35599000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1003000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	665000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	133000	USD
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000000	USD
CY2016Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3045000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3006000	USD
CY2015Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	1425000	USD
CY2016Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17444000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20936000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-339414000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-365674000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2402000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3915000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	335459000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	313701000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41220989	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46184134	shares

Files In Submission

Name	View Source	Status
0001117480-16-000045-index-headers.html	Edgar Link	pending
0001117480-16-000045-index.html	Edgar Link	pending
0001117480-16-000045.txt	Edgar Link	pending
0001117480-16-000045-xbrl.zip	Edgar Link	pending
a20160331cmrx10-qdocument.htm	Edgar Link	pending
a20160331cmrxex-101.htm	Edgar Link	pending
a20160331cmrxex-102.htm	Edgar Link	pending
a20160331cmrxex-311.htm	Edgar Link	pending
a20160331cmrxex-312.htm	Edgar Link	pending
a20160331cmrxex-321.htm	Edgar Link	pending
a20160331cmrxex-322.htm	Edgar Link	pending
cmrx-20160331.xml	Edgar Link	completed
cmrx-20160331.xsd	Edgar Link	pending
cmrx-20160331_cal.xml	Edgar Link	unprocessable
cmrx-20160331_def.xml	Edgar Link	unprocessable
cmrx-20160331_lab.xml	Edgar Link	unprocessable
cmrx-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2016 Q2 Form 10-Q Financial Statement

#000111748016000045 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2016 Q2 Form 10-Q Financial Statement

#000111748016000045 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx